Ayla - the digital Cognitive
Stimulation Therapy (CST)
platform
Cognitive Stimulation Therapy is the world's leading clinically proven non-drug dementia therapy adopted in 39 countries
A multi-modal group therapy for managing mild to moderate dementia, 85% of all cases
Evidence based on clinical benefits based on 2766 patients:
7 weeks (2 sessions per week) 8-15 per group
6 months delay in cognitive decline
Improved communication
Improved quality of life
Increase social interaction and confidence
Cost effective for healthcare system implementation
NICE recommended (National Institute for Care Excellence)
Supported by two systematic Cochrane Reviews
Recommended for global implementation by the world Alzheimer report
CST sources:
Yet, CST can be challenging to offer
Time intensive paper-based session
No standard approach to delivery
Content creation is time consuming
Constant need for adapting content to the group
Meet Ayla
your CST Assistant
14 fullCST sessions
- 180+ expertly validated CST activities
- Cognitively stimulating and demographically suitable
- Digital guidance through a session
Easily
adaptable
- Adaptable content ensures maximum stimulation and engagement
- Easy-to-use filters based on cognitive and physical ability of patients
- Additional printable material and tips for best practice
Clinically
relevant
- Standardized approach to enhance patient outcomes
- Reduction in preparation time by 50%*
- Equivalent patient outcomes to CST
*based on DK and AgeUK usability study
Ayla for healthcare providers
offer engaging, adaptable and clinically relevant Cognitive Stimulation Therapy (CST)
Ayla for patients and carers
Help us in the development of our Home Companion, the first product directly aimed to help people with dementia. The Home Companion will assist you or a loved one in cognitive stimulation and living with dementia.
Ayla for investors
financials and corporate actions as we build our digital dementia care platform.
